AU Stock MarketDetailed Quotes

RAD Radiopharm Theranostics Ltd

Watchlist

0.030
0.0000.00%

20min DelayNot Open Jun 18 16:00 AET

13.81MMarket Cap-280P/E (Static)

Radiopharm Theranostics Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Jun 30, 2023

(FY)Jun 30, 2022

Total revenue

3,210.60%292.36K

8.83K

Operating revenue

3,210.60%292.36K

--8.83K

Cost of revenue

Gross profit

3,210.60%292.36K

8.83K

Operating expense

74.66%34.8M

19.93M

Selling and administrative expenses

20.03%13.02M

--10.85M

-General and administrative expense

20.03%13.02M

--10.85M

Research and development costs

234.58%13.8M

--4.12M

Depreciation amortization depletion

10.57%3.3M

--2.98M

-Depreciation and amortization

10.57%3.3M

--2.98M

Other operating expenses

137.56%4.68M

--1.97M

Operating profit

-73.27%-34.51M

-19.92M

Net non-operating interest income (expenses)

100.63%58.94K

-9.35M

Non-operating interest income

--145.04K

----

Non-operating interest expense

-99.08%86.09K

--9.35M

Other net income (expenses)

87.94%-124.05K

-1.03M

Special income (charges)

---3.1M

----

-Less:Impairment of capital assets

--3.1M

----

Other non-operating income (expenses)

389.35%2.98M

---1.03M

Income before tax

-14.12%-34.57M

-30.29M

Income tax

-14.40%38.01K

44.4K

Earnings from equity interest net of tax

Net income

-14.08%-34.61M

-30.34M

Net income continuous operations

-14.08%-34.61M

---30.34M

Noncontrolling interests

Net income attributable to the company

-14.08%-34.61M

-30.34M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-14.08%-34.61M

-30.34M

Diluted earnings per share

30.05%-0.1069

-0.1528

Basic earnings per share

30.05%-0.1069

-0.1528

Dividend per share

Accounting Standards

US-GAAP

US-GAAP

	(FY)Jun 30, 2023	(FY)Jun 30, 2022
Total revenue	3,210.60%292.36K	8.83K
Operating revenue	3,210.60%292.36K	--8.83K
Cost of revenue
Gross profit	3,210.60%292.36K	8.83K
Operating expense	74.66%34.8M	19.93M
Selling and administrative expenses	20.03%13.02M	--10.85M
-General and administrative expense	20.03%13.02M	--10.85M
Research and development costs	234.58%13.8M	--4.12M
Depreciation amortization depletion	10.57%3.3M	--2.98M
-Depreciation and amortization	10.57%3.3M	--2.98M
Other operating expenses	137.56%4.68M	--1.97M
Operating profit	-73.27%-34.51M	-19.92M
Net non-operating interest income (expenses)	100.63%58.94K	-9.35M
Non-operating interest income	--145.04K	----
Non-operating interest expense	-99.08%86.09K	--9.35M
Other net income (expenses)	87.94%-124.05K	-1.03M
Special income (charges)	---3.1M	----
-Less:Impairment of capital assets	--3.1M	----
Other non-operating income (expenses)	389.35%2.98M	---1.03M
Income before tax	-14.12%-34.57M	-30.29M
Income tax	-14.40%38.01K	44.4K
Earnings from equity interest net of tax
Net income	-14.08%-34.61M	-30.34M
Net income continuous operations	-14.08%-34.61M	---30.34M
Noncontrolling interests
Net income attributable to the company	-14.08%-34.61M	-30.34M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders	-14.08%-34.61M	-30.34M
Diluted earnings per share	30.05%-0.1069	-0.1528
Basic earnings per share	30.05%-0.1069	-0.1528
Dividend per share
Accounting Standards	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

AU

Overall